Viewing Study NCT01461005


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT01461005
Status: TERMINATED
Last Update Posted: 2020-02-19
First Post: 2011-10-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)
Sponsor: Paradigm Spine
Organization:

Study Overview

Official Title: A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)
Status: TERMINATED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: FDA reclassified so all 522 studies were stopped,
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DSS
Brief Summary: The purpose of the Post-Market Surveillance study is to evaluate safety.
Detailed Description: Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center, literature controlled study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: